These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32933403)

  • 1. Progress in systemic co-delivery of microRNAs and chemotherapeutics for cancer treatment by using lipid-based nanoparticles.
    He W; Turkeshi A; Li X; Zhang H
    Ther Deliv; 2020 Sep; 11(9):591-603. PubMed ID: 32933403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
    Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
    J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale delivery systems for microRNAs in cancer therapy.
    Boca S; Gulei D; Zimta AA; Onaciu A; Magdo L; Tigu AB; Ionescu C; Irimie A; Buiga R; Berindan-Neagoe I
    Cell Mol Life Sci; 2020 Mar; 77(6):1059-1086. PubMed ID: 31637450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanocarriers for microRNA delivery.
    Scheideler M; Vidakovic I; Prassl R
    Chem Phys Lipids; 2020 Jan; 226():104837. PubMed ID: 31689410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan nanocarriers for microRNA delivery and detection: A preliminary review with emphasis on cancer.
    Sargazi S; Siddiqui B; Qindeel M; Rahdar A; Bilal M; Behzadmehr R; Mirinejad S; Pandey S
    Carbohydr Polym; 2022 Aug; 290():119489. PubMed ID: 35550773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.
    Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z
    J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic delivery of small RNA using lipid nanoparticles.
    Asai T; Oku N
    Biol Pharm Bull; 2014; 37(2):201-5. PubMed ID: 24492716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi therapeutics and applications of microRNAs in cancer treatment.
    Uchino K; Ochiya T; Takeshita F
    Jpn J Clin Oncol; 2013 Jun; 43(6):596-607. PubMed ID: 23592885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-targeted therapeutics for lung cancer treatment.
    Xue J; Yang J; Luo M; Cho WC; Liu X
    Expert Opin Drug Discov; 2017 Feb; 12(2):141-157. PubMed ID: 27866431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment.
    Yadav A; Singh S; Sohi H; Dang S
    AAPS PharmSciTech; 2021 Dec; 23(1):25. PubMed ID: 34907501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
    Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
    Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.
    Nguyen MA; Wyatt H; Susser L; Geoffrion M; Rasheed A; Duchez AC; Cottee ML; Afolayan E; Farah E; Kahiel Z; Côté M; Gadde S; Rayner KJ
    ACS Nano; 2019 Jun; 13(6):6491-6505. PubMed ID: 31125197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What does the future hold for chemotherapy with the use of lipid-based nanocarriers?
    Pucci C; Martinelli C; Ciofani G
    Future Oncol; 2020 Feb; 16(5):81-84. PubMed ID: 31872773
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
    Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
    ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-based drug delivery systems for cancer treatment.
    Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
    Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-viral based miR delivery and recent developments.
    Labatut AE; Mattheolabakis G
    Eur J Pharm Biopharm; 2018 Jul; 128():82-90. PubMed ID: 29679644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials.
    Kabil MF; Badary OA; Bier F; Mousa SA; El-Sherbiny IM
    J Liposome Res; 2024 Mar; 34(1):135-177. PubMed ID: 37144339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
    Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
    Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.